Literature DB >> 7883449

The chemosensitivity of the rodent malarias--relationships with the biology of merozoites.

A Beauté-Lafitte1, V Altemayer-Caillard, F Gonnet-Gonzalez, L Ramiaramanana, A G Chabaud, I Landau.   

Abstract

According to the hypothesis proposed by Landau, Cambie & Chabaud (1990, Annalees de Parasitologie Humaine et Comparée 65: 101-103), the chemoresistance of malaria is related to the selection of strains with latent merozoites, the latter being capable of penetrating into red blood cells at other times than that of the time of schizogony and reinfect the host with as much of a delay as several days. They determine an asynchronism of the schizogonic rhythm and, being so far resistant to all known medication, should induce, at least to some extent, a chemoresistance. Consequently, there are three factors linked to merozoites: latency, asynchronism and chemoresistance. The relationship between asynchronism and latency of merozoites has been demonstrated previously (Cambie, Landau & Chabaud, 1990, Compte Rendus de l'Academie des Sciences de Paris 310: 183-188.). In the present work it was shown that the two classifications of strains, first in order of increasing chloroquine resistance, second in order of increasing degree of persistance of merozoites in the blood, are almost identical for the 10 strains, subspecies or species of Plasmodium considered. The relationship between latency of merozoites and chemoresistance appears to have been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7883449     DOI: 10.1016/0020-7519(94)90163-5

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  7 in total

Review 1.  Antiplasmodial marine natural products in the perspective of current chemotherapy and prevention of malaria: a review.

Authors:  Dominique Laurent; Francesco Pietra
Journal:  Mar Biotechnol (NY)       Date:  2006-03-30       Impact factor: 3.619

2.  Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.

Authors:  Brioni R Moore; Madhu Page-Sharp; Jillian R Stoney; Kenneth F Ilett; Jeffrey D Jago; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

3.  Characterization of the potent in vitro and in vivo antimalarial activities of ionophore compounds.

Authors:  C Gumila; M L Ancelin; A M Delort; G Jeminet; H J Vial
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 4.  Choline analogues in malaria chemotherapy.

Authors:  Suzanne Peyrottes; Sergio Caldarelli; Sharon Wein; Christian Périgaud; Alain Pellet; Henri Vial
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism.

Authors:  Marie L Ancelin; Michèle Calas; Anne Bonhoure; Serge Herbute; Henri J Vial
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

6.  The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.

Authors:  Anna L Goodman; Emily K Forbes; Andrew R Williams; Alexander D Douglas; Simone C de Cassan; Karolis Bauza; Sumi Biswas; Matthew D J Dicks; David Llewellyn; Anne C Moore; Chris J Janse; Blandine M Franke-Fayard; Sarah C Gilbert; Adrian V S Hill; Richard J Pleass; Simon J Draper
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  Protective Immunity in Mice Immunized With P. vivax MSP119-Based Formulations and Challenged With P. berghei Expressing PvMSP119.

Authors:  Irina Dobrescu; Tarsila Mendes de Camargo; Alba Marina Gimenez; Oscar Murillo; Kelly Nazaré da Silva Amorim; Claudio Romero Farias Marinho; Irene Silva Soares; Silvia Beatriz Boscardin; Daniel Youssef Bargieri
Journal:  Front Immunol       Date:  2020-02-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.